Lilly is the third company to partner with Sangamo on STAC-BBB after Astellas Gene Therapies, which paid $20 million upfront ...

The upcoming Eredivisie match between Feyenoord and Groningen is generating significant buzz among football enthusiasts. As both teams prepare to clash, there are numerous factors to consider ...

Who Will Prevail in the Battle of Offense and Defense? As one of the most exciting leagues in European football, the Eredivisie offers thrilling matches filled with passion and suspense. This Tuesday, ...

VectorY Therapeutics has appointed Olga Uspenskaya-Cadoz as Chief Medical Officer. The appointment strengthens the clinical ...

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS ® platform to develop in vivo gene editing therapies for high unmet need ...

MANILA, Philippines — Overcast skies and rains will prevail on Thursday due to the effects of the shear line and the northeast monsoon or amihan, according to the state weather bureau.

Scribe’s partners include Eli Lilly-owned Prevail Therapeutics (an up to $1.5 billion neuro-focused collaboration launched in 2023)—and Sanofi, from which Scribe in January received a ...

the company also have active partnerships with Novartis AG (NVS), Caribou Biosciences (CRBU), and Prevail Therapeutics. However, given that, to date, Precision has not announced major changes in ...

Viking Therapeutics' stock declined by 37% following a downgrade to "hold" in December, anticipating competitive pressures from Novo Nordisk's CagriSema Phase 3 results. The company's GIP/GLP-1 ...

Dr. Sevigny is a physician-scientist with more than 15 years of leadership in translational and clinical drug development, including as chief medical officer at Prevail Therapeutics, a wholly ...

BOSTON and SAN DIEGO, March 11, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the ...